Apollo Medical Competitors

FTI Consulting (NYSE:FCN) and Apollo Medical (NASDAQ:AMEH) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations and price targets for FTI Consulting and Apollo Medical, as provided by MarketBeat.

FTI Consulting currently has a consensus target price of $163.00, indicating a potential upside of 54.27%. Given FTI Consulting's higher possible upside, equities analysts clearly believe FTI Consulting is more favorable than Apollo Medical.

Earnings & Valuation

This table compares FTI Consulting and Apollo Medical's top-line revenue, earnings per share and valuation.

FTI Consulting has higher revenue and earnings than Apollo Medical. FTI Consulting is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

FTI Consulting has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

Profitability

This table compares FTI Consulting and Apollo Medical's net margins, return on equity and return on assets.

Institutional & Insider Ownership

8.5% of Apollo Medical shares are owned by institutional investors. 2.2% of FTI Consulting shares are owned by insiders. Comparatively, 11.9% of Apollo Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

FTI Consulting beats Apollo Medical on 8 of the 13 factors compared between the two stocks.

Apollo Medical (NASDAQ:AMEH) and ICF International (NASDAQ:ICFI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Apollo Medical and ICF International, as reported by MarketBeat.com.

ICF International has a consensus price target of $91.80, indicating a potential upside of 23.47%. Given ICF International's higher possible upside, analysts plainly believe ICF International is more favorable than Apollo Medical.

Risk & Volatility

Apollo Medical has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, ICF International has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500.

Valuation and Earnings

This table compares Apollo Medical and ICF International's revenue, earnings per share and valuation.

ICF International has higher revenue and earnings than Apollo Medical. ICF International is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

8.5% of Apollo Medical shares are held by institutional investors. 11.9% of Apollo Medical shares are held by insiders. Comparatively, 4.3% of ICF International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Apollo Medical and ICF International's net margins, return on equity and return on assets.

Summary

ICF International beats Apollo Medical on 8 of the 13 factors compared between the two stocks.

Apollo Medical (NASDAQ:AMEH) and The RMR Group (NASDAQ:RMR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Profitability

This table compares Apollo Medical and The RMR Group's net margins, return on equity and return on assets.

Volatility & Risk

Apollo Medical has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, The RMR Group has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.

Valuation & Earnings

This table compares Apollo Medical and The RMR Group's gross revenue, earnings per share (EPS) and valuation.

The RMR Group has higher revenue and earnings than Apollo Medical. The RMR Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

8.5% of Apollo Medical shares are owned by institutional investors. Comparatively, 39.7% of The RMR Group shares are owned by institutional investors. 11.9% of Apollo Medical shares are owned by company insiders. Comparatively, 55.1% of The RMR Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Apollo Medical and The RMR Group, as provided by MarketBeat.

The RMR Group has a consensus target price of $33.30, indicating a potential downside of 4.69%. Given The RMR Group's higher probable upside, analysts clearly believe The RMR Group is more favorable than Apollo Medical.

Summary

The RMR Group beats Apollo Medical on 10 of the 13 factors compared between the two stocks.

Huron Consulting Group (NASDAQ:HURN) and Apollo Medical (NASDAQ:AMEH) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk.

Insider and Institutional Ownership

86.6% of Huron Consulting Group shares are held by institutional investors. Comparatively, 8.5% of Apollo Medical shares are held by institutional investors. 2.2% of Huron Consulting Group shares are held by insiders. Comparatively, 11.9% of Apollo Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Huron Consulting Group and Apollo Medical's gross revenue, earnings per share (EPS) and valuation.

Huron Consulting Group has higher revenue and earnings than Apollo Medical. Huron Consulting Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Huron Consulting Group has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Huron Consulting Group and Apollo Medical, as reported by MarketBeat.com.

Huron Consulting Group presently has a consensus target price of $63.3333, suggesting a potential upside of 44.60%. Given Huron Consulting Group's higher possible upside, equities analysts plainly believe Huron Consulting Group is more favorable than Apollo Medical.

Profitability

This table compares Huron Consulting Group and Apollo Medical's net margins, return on equity and return on assets.

Summary

Huron Consulting Group beats Apollo Medical on 8 of the 13 factors compared between the two stocks.

Apollo Medical (NASDAQ:AMEH) and The Hackett Group (NASDAQ:HCKT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk.

Earnings and Valuation

This table compares Apollo Medical and The Hackett Group's gross revenue, earnings per share and valuation.

The Hackett Group has lower revenue, but higher earnings than Apollo Medical. The Hackett Group is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Apollo Medical and The Hackett Group's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Apollo Medical and The Hackett Group, as provided by MarketBeat.

The Hackett Group has a consensus price target of $18.00, indicating a potential upside of 20.97%. Given The Hackett Group's higher possible upside, analysts plainly believe The Hackett Group is more favorable than Apollo Medical.

Risk & Volatility

Apollo Medical has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, The Hackett Group has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Institutional and Insider Ownership

8.5% of Apollo Medical shares are held by institutional investors. Comparatively, 79.6% of The Hackett Group shares are held by institutional investors. 11.9% of Apollo Medical shares are held by insiders. Comparatively, 17.3% of The Hackett Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

The Hackett Group beats Apollo Medical on 9 of the 13 factors compared between the two stocks.

BlackRock Capital Investment (NASDAQ:BKCC) and Apollo Medical (NASDAQ:AMEH) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation & Earnings

This table compares BlackRock Capital Investment and Apollo Medical's gross revenue, earnings per share (EPS) and valuation.

Apollo Medical has higher revenue and earnings than BlackRock Capital Investment. BlackRock Capital Investment is trading at a lower price-to-earnings ratio than Apollo Medical, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

29.8% of BlackRock Capital Investment shares are owned by institutional investors. Comparatively, 8.5% of Apollo Medical shares are owned by institutional investors. 1.6% of BlackRock Capital Investment shares are owned by company insiders. Comparatively, 11.9% of Apollo Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares BlackRock Capital Investment and Apollo Medical's net margins, return on equity and return on assets.

Volatility and Risk

BlackRock Capital Investment has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Apollo Medical has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations for BlackRock Capital Investment and Apollo Medical, as provided by MarketBeat.com.